Study findings were published recently in Clinical Research in Cardiology. Its lead author, Richard Becker, MD, professor of medicine in the UC College of Medicine, says the patch is easier for ...

Despite a net loss and cash constraints, HeartBeam Inc (BEAT) remains optimistic about FDA clearance and its groundbreaking ECG technology.

SANTA CLARA, Calif., November 07, 2024 -- ( BUSINESS WIRE )-- HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company ...

The global stress tracking devices market is on a promising growth trajectory, with an estimated valuation of USD 2.5 billion in 2023, anticipated to nearly double to USD 4.7 billion by 2033.